Early on demand or prophylactic therapy to replace the missing coagulation factor in patients with bleeding disorders can effectively control or prevent acute bleeding.

Haematology

Our medicines replace the missing coagulation factor in patients with bleeding disorders to effectively control or prevent bleeding.

Haematology 

It is the use of immunoglobulin (IgG) medicines to help the body’s own immune system fight infections or immune mediated diseases. 

Immunotherapy

Intensive care and emergency medicine patients require immediate medical attention to prevent shock and quickly restore the body's natural balance such as blood volume and clotting function.

Critical Care

Our medicines prevent shock and quickly restore blood volume and clotting function in patients in intensive care and emergency medical situations.

Critical care

We develop and manufacture medicines for patients in three therapeutically areas - haematology, immunotherapy and critical care.